Icap expands equity presence by buying Link

Icap will pay £135 million initially for the broker, plus up to £30 million for its assets over and above regulatory capital requirements, and an earnout based on after-tax profits in 2010. The total payment is capped at £250 million.

The takeover will be debt-financed, according to Icap - it has agreed a £150 million term loan and also recently signed a three-year £520 million senior revolver deal.

The move will strengthen Icap within the fragmented equity derivatives market, where Link is a strong performer - in last year's Risk interdealer broker rankings it came third, behind Sunrise and GFI but ahead of Icap, which came fifth.

Icap plans to combine Link, including its chairman John Booth and chief executive Charles Davies, with its existing non-US equity derivatives business. Icap chief executive Michael Spencer commented: "Equity derivatives are one of the 'focus' areas for our voice business that we have identified as having faster structural growth opportunities. The market has expanded hugely during the past five to seven years as a result of the search for yield, the demand for absolute returns and the emergence of volatility as a traded asset class in its own right."

Notional outstanding volumes of equity derivatives have grown sharply, according to the International Swaps and Derivatives Association. In June 2007, the most recent month for which figures are available, the total was $9.2 trillion, up from $7.5 trillion in December 2006 and $4.6 trillion in June 2005.

See also: Icap expands property derivatives business into Asia-Pacific 
A two-front war 
Capping it all

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here